# Comparing the Prognosis of Patients With HCC and PVTT Treated With Surgery Versus Locoregional Therapy.

> **NCT06248528** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Chen Xiaoping** · enrollment: 1076 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **PROCEDURE:** Liver resection
- **PROCEDURE:** Locoregional therapy

## Key facts

- **NCT ID:** NCT06248528
- **Lead sponsor:** Chen Xiaoping
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-12-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2027-01-31
- **Target enrollment:** 1076 (ACTUAL)
- **Last updated:** 2025-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06248528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06248528, "Comparing the Prognosis of Patients With HCC and PVTT Treated With Surgery Versus Locoregional Therapy.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06248528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*